Catalyst Wire Dossier Catalyst Wire Dossier

DEFERASOROX

DEFERASIROX · Novadoz Pharmaceuticals LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DEFERASOROX, covering 2021-03-17 to 2024-10-23. Get the full timeline:

Most recent: FDA Approved: DEFERASOROX — Supplemental Application (Novadoz Pharmaceuticals LLC)

See pricing